The aim of the present study is to evaluate the functional status, life quality, mood and functionality of the adult patients with juvenile idiopathic arthritis (JIA) in Turkish population. Forty-seven patients with JIA were included in the study. Demographic features, disease characteristics, number of tender and swollen joints, pain score according to visual analogue scale and disease activity according to Disease Activity Score 28 (DAS28) were calculated and recorded. Functional disability was evaluated with a modified Health Assessment Questionnaire (m-HAQ). Quality of life was evaluated with Arthritis Impact Measurement Scale-2 (AIMS-2). Mood status was evaluated with Beck Depression Inventory (BDI) and Beck Anxiety Inventory (BAI). The average DAS28 score of the patients was 4.37. Mean m-HAQ score was 1.25. According to AIMS-2 subscales, the average mobility level score was 5.5, walking and bending score was 6.0, hand and finger function score was 5.0, arm function score was 3.5, self-care score was 2.5, household tasks score was 3.75, social activities score was 6.0, support from family and friends score was 3.13, arthritis pain score was 6.0, level of tension score was 5.5, mood score was 6.0, satisfactory of health score was 7.31, and the general perception of health score was 5.0. The average BDI score was 19.0 while BAI score was 20.0. Although patients have mild disease activity and functional disability, their mood status and life quality are better. Patients may adapt to their disability status and survive their functional independence.
Introduction
Juvenile idiopathic arthritis (JIA) can be described as arthritis persists at least 6 weeks which begin before 16 years of age [1] . It is the most common chronic, inflammatory, rheumatic disease in childhood and adolescence. Estimated prevalence of JIA ranges from 16 to 150 persons per 100,000 [2] . Regarding spontaneous remission during the course of the disease, the outcomes of the patients are generally considered as relatively "good" [3] . However, these patient groups carry chronical sequelae of the disease from childhood and adolescence to adulthood which are associated with decreased quality of life (QoL) and functional level.
The long-term outcomes of young adults with JIA are a variable [4, 5] . Evaluation of such chronic juvenile rheumatic diseases should be multidimensional because outcomes are multifactorial. National health care programmes, rehabilitation and care policies and individual's and society's point of view to the disease are strongly associated with outcomes [6, 7] . Besides, the level of education, employment and social and marital status are among important long-term determinants which indicate possibilities for patients for participation in social life [8] . Health-related quality of life (HrQoL) is an important goal for treatment which encompasses physical, emotional, social and behavioural well-being and functioning [9, 10] . In adulthood, individuals generally have no clinical evidence of active joint disease but other joint sequelae due to previous inflammation or treatment such as joint failure requiring replacement surgery, visual loss due to persistent uveitis, growth retardation or osteoporosis may have detrimental effects on QoL [11] . Furthermore, the impact of physiological determinants to patient's life is an apparent situation [12] .
Several studies have shown that JIA patients have significantly lower HRQoL compared to healthy subjects [13, 14] . The assessment of HRQoL was often conducted several years after the diagnosis but not in adulthood in these studies [15] , and it is still unclear why the patients with clinically inactive disease are associated with reduced quality of life [16] . The aim of the present study is to evaluate the functional status, QoL mood status and health perception of the adult patients with JIA in Turkish population.
Material and Methods

Patients
Forty-seven patients with the diagnosis of JIA according to the criteria of the International League of Associations for Rheumatism (ILAR) and who were followed by outpatient clinic previously and who were over 18 years old with at least 5 years of disease duration and treated with same medication for the last 6 months were included in the study. Patients with severe endocrine and metabolic disease, systemic disease, connective tissue diseases such as Sjogren's syndrome and scleroderma, progressive or non-progressive neurological disease including peripheral neuropathies, malignancy, orthopaedic surgery of extremities, psychiatric disease and who use antidepressants or anxiolytics were excluded. The study was approved by local ethical committee (S.B 2013-19/03) and conducted in accordance with the ethical standards of the local and institutional research committees and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
Demographic and Disease Characteristics
Demographic characteristics of the subjects including age, gender, educational level, marital status and disease characteristics including duration of disease and diagnosis, presence/ duration of morning stiffness, the number of tender and swollen and limited joints were recorded.
Biochemical Parameters
Patients were evaluated with erythrocyte sedimentation rate (ESR) (0-100 mm/h), C reactive protein (CRP) (0-5 μg/dl) and rheumatoid factor (RF) (0-20 IU/mL).
Disease Activity Assessment
The Disease Activity Score 28 (DAS28) is a system developed and validated by the EULAR (European League Against Rheumatism) to measure the progress and improvement of rheumatoid arthritis (RA). DAS28 is often used in clinical trials for the development of RA. DAS28 values range from 2.0 to 10.0 while higher values mean a higher disease activity.
The DAS28 is a development of the DAS which is more complex with regard to assessment. "28" describes the number of different joints included in the measurement as follows: p r o x i m a l i n t e r p h a l a n g e a l j o i n t s ( 1 0 j o i n t s ) , metacarpophalangeal joints (10), wrists (2), elbows (2), shoulders (2) and knees (2) .
When looking at these joints, both the number of joints with tenderness upon touching (TJ) and swelling (SJ) are counted. In addition, the ESR is measured. Also, the patient makes a subjective assessment (SA) of disease activity during the preceding 7 days on a scale between 0 and 100, where 0 is "no activity" and 100 is "highest activity possible". With the mentioned parameters, DAS28 is calculated with 0.56 × (TJ) 2 + 0.28 × (SJ) 2 + 0.7 × (ESR) + 0.014 × SA formulation. A DAS28 value over 5.1 corresponds to a high disease activity, a DAS28 value between 3.2 and 5.1 is associated with moderate disease activity, a DAS28 value between 2.6 and 3.2 refers to a low disease activity and a DAS28 value under 2.6 means remission.
Functional Level Assessment
The functional level of the patients is evaluated with a modified Health Assessment Questionnaire (m-HAQ) which is derived from a Health Assessment Questionnaire (HAQ) by reducing 20 activities to 8 including dressing and grooming, arising, eating, walking, hygiene, reach, grip and common daily activities. Patients were asked to rate these daily activities as "without difficulty" (0 point), "with some difficulty" (1 point), "with much difficulty" (2 points) and "unable to do" (3 points). m-HAQ score is calculated as the average of the single scores. Scores under 0.3 are considered as normal.
Quality of Life (QoL) Assessment
Quality of life of patients was assessed by subscales of Arthritis Impact Measurement Scale-2 (AIMS-2). The AIMS-2 contains 78 items, and the first 57 are grouped into 12 scales. The 12 scales can be further grouped into 5 components: physical (mobility, walking and bending, hand and finger function, arm function, self-care and household tasks), symptoms (arthritis pain), role (work), social Interaction (social activities and support) and affect (level of tension and mood). A further 44 items cover satisfaction with health, the impact of arthritis on functioning and priorities for improvement. Of the 12 scales, each was scored individually from 1 to 5 (0-10 points). Higher scores are associated with worse quality of life.
Assessment of Mood
Mood status was evaluated using Beck Depression Inventory (BDI) and Beck Anxiety Inventory (BAI). BDI and BAI are both 21-questions multiple-choice self-report inventories and are widely used in psychometric tests for measuring the severity of depression and anxiety. For depression, 17 points and over are significant; for anxiety, 10 points and over are significant.
Comparisons
Patients were classified as remission (< 2.6), low disease activity (2.6-3.2), mild disease activity (3.2-5.1) and severe disease activity (> 5.1) according to DAS28 scores. Disease activity, biochemical parameters, functional disability, mood status and quality of life parameters were compared between groups.
Statistical Analysis
Statistical Package for the Social Sciences (SPSS 22.0 for Windows) software was used to analyse the data. The continuous variables were evaluated with the Kolmogorov-Smirnov test to check if they are different from normal distribution. In descriptive statistics, the data were expressed as mean ± standard deviation for continuous variables, and as frequencies and percentages (%) for nominal variables using the chisquare test. To compare disease activity groups according to DAS28 with evaluation parameters, ANOVA test was used. For subgroup comparisons, Tukey's LSD post hoc analysis was used. The results were considered as significant for p < 0.05.
Results
All patients were female and mean age was 43.34 ± 12.39 years. The mean duration of disease was 31.12 ± 13.16 years while the mean duration after diagnosis was 14.57 ± 9.38. The mean duration of the morning stiffness reported by the patients was 51.06 ± 73.08 min. The mean number of tender, swollen and stiffed joints were 8.85 ± 8.11, 2.61 ± 1.91 and 21.85 ± 13.52, respectively. The mean VAS score of the patients was 4.17 ± 2.66 cm. The mean ESR (mm/h) and CRP (μg/dl) were 26.55 ± 18.17 and 13.29 ± 20.18, respectively. The mean DAS28 score of the patients was 4.37 ± 1.52. The demographic and disease characteristics of the subjects are given in Table 1 .
The mean total QoL score of the patients was 5.83 ± 1.96. According to AIMS-2 subscales, the mean mobility level score was 5.90 ± 1.26 while walking and bending score was 6.63 ± 2.28. According to functional evaluation, the mean hand and finger and arm function scores were 5.67 ± 2.46 and 4.14 ± 2.29, respectively. The mean self-care score was found as 3.88 ± 2.05 and the mean household task score was found 3.71 ± 2.19. The mean social activities score determinant of AIMS-2 was found 6.01 ± 1.23 while the mean support from family and friends score determinant was 3.75 ± 2.34. In terms of pain perception, the mean arthritis pain score was found as 7.22 ± 1.79. The mean mood score of the patients was found 6.22 ± 1.68 while the mean level of tension score was 6.04 ± 1.74. In terms of health perception, the mean satisfactory of health score was 5.11 ± 1.92 while the mean general perception of health score was 6.79 ± 2.38. The mean total functional disability score according to m-HAQ was 1.44 ± 0.70. In terms of mood evaluation, we found the mean BDI and BAI scores 20.25 ± 13.46 and 21.80 ± 12.19, respectively. Functional disability, mood status and quality of life scores of the patients are given in Table 2 .
Ten of the patients had low disease activity (21.3%), 8 had mild disease activity (17%) and 29 had severe disease activity (61.7%). The classification of the patients according to disease activity and their comparison with evaluation parameters are given at Table 3 . Walking and bending, hand and finger function and m-HAQ scores were significantly lower in low disease group compared to mild disease activity group (p = 0.034, p = 0.014 and p = 0.001, respectively) as well as severe disease activity group (p = 0.041, p = 0.017 and p = 0.001, respectively). Mobility, arm function and household tasks were significantly lower in low disease activity group compared to severe disease activity group (p = 0.034, p = 0.001 and p = 0.037, respectively).
Discussion
JIA is the most common rheumatic disease of children and adolescents which may have detrimental effects to the patients' entire life. Although the disease is generally considered with good outcomes, considerably high number, at least one third of the patients may have ongoing sequelae in adulthood [17] . In our study, we found significantly poorer outcomes in important daily life activities such as walking and bending, hand and finger function, arm function, mobility and household tasks in severe disease activity group compared to low disease activity group. In accordance with this data, we found significantly higher m-HAQ scores in severe disease activity group which indicates a worse functional level. Surprisingly, we found no significant difference in terms of arthritic pain, satisfactory of health and general perception of health suggesting that our patients' group adapt their disabilities and pain although they have severe disease activity. Generalisation of our results to all JIA population in Turkey may be limited because we used hospital data. This situation may inadvertently give rise to a bias in favour of severe disease activity. To avoid this bias partly, and to unify patients population as much as possible, we only focused on the patient group with at least 5 years of disease duration and 6 months of the same medication. The mean disease duration was 31.12 ± 13.16 years and the mean DAS28 score of all 47 patients was 4.37 ± 1.52 indicating an overall mild disease activity in our study. These are identical for our study for the similar ones in literature and might be taken as evidence for the absence of major bias in patient selection. The third decade of an individual is associated with major life goals. Educational goals are generally completed, and the person participates in labour force and sets new family. Although there is importance of this period, it is generally undermined in previous studies [18] . Previous studies about the educational achievement of patients with JIA reported generally comparable or higher educational level [19, 20] . In a previous study, Archenholtz et al. have reported lower educational level in early adult life in patients with JIA [21] . Our results are in accordance with the study and 63.8% of our patients have had a primary school degree.
The results of Qol or HrQoL in adult patients with JIA are somehow controversial and depend on the tool used for the study. However, there is a consensus that although physical domains of the tools indicate a poorer life quality, mental domains are generally comparable to healthy subjects [22] . We used AIMS-2 scale like Umay et al. because this scale evaluates the functional status and daily activities of the patients better [23] . We also used m-HAQ to evaluate the functional disability and to correlate disability level with disease activity and life quality. According to physical activity domains of AIMS-2, walking and bending function was found to be the reduce quality of life the most. The mean AIMS-2 score of all individuals was 5.84 and HAQ score was 1.44. High AIMS-2 scores despite low m-HAQ scores suggest that our patient group adapt their disabilities although they have a lower quality of life as disease duration elongates.
Data about the importance of mood status and the real impact of physiological factors on life quality in adult patients with JIA is very poor and should be investigated. The opinions about this issue are limited to life quality tools like SF-36 or AIMS-2 [24, 25] . The impact of mood status on disease activity is well known in adults and should be important in chronic arthritic conditions like JIA [26] . Besides the mental domain of AIMS-2, we used BAI and BDI in our study identically. We did not find any significant difference between low, mild and severe disease activity groups suggesting that the patients were generally in good mood status despite their functional impairment. This was in accordance with mental domains of AIMS-2 in terms of the level of tension and mood status.
The main limitation of our study is the limited number of patients. Another relative limitation is a bias towards severe disease activity group. In fact, as expressed previously, we tried to focus on a limited group of patients to avoid this bias partly and to put forth the exact effect of the ongoing sequels of the disease on quality life.
Conclusions
The impact of JIA on the quality and health-related quality of life measures in adulthood is an important issue but the data is still lacking. In the present study, we found that although patients have mild disease activity and functional disability, their mood status and life of quality are better. Patients may adapt to their disability status and survive their functional independence.
